- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 09.10. | Fierce Pharma Asia-Novartis' $7.8B mRNA deal; Shionogi's $2B buy; ArriVent's phase 3 flop | 8 | FiercePharma | ||
| 07.10. | Shionogi to Acquire IntraBio, Adding Aqneursa to Rare Disease Portfolio | 3 | Contract Pharma | ||
| 06.10. | Shionogi bolsters rare disease portfolio with $2bn IntraBio buyout | 3 | Pharmaceutical Technology | ||
| 05.10. | Shionogi Adds to Its Rare Disease Strategy With $2B IntraBio Acquisition | 3 | MedCity News | ||
| 05.10. | Shionogi pays $2B to acquire a rare disease startup | 3 | BioPharma Dive | ||
| SHIONOGI & CO LTD ADR Aktie jetzt für 0€ handeln | |||||
| 05.10. | Shionogi agrees $2bn deal for IntraBio and its rare-neurology drug AQNEURSA | 3 | Tokyo Brief | ||
| 05.10. | Shionogi's diversification continues with $2bn IntraBio buy | 3 | pharmaphorum | ||
| 25.09. | Shionogi Amends Annual Report, Cuts Disclosed Director Pay Total | 3 | Tokyo Brief | ||
| 16.09. | Shionogi Wins Booster Approval for Its COVID-19 Vaccine, But Won't Sell It This Season | 3 | Tokyo Brief | ||
| 16.09. | Shionogi's Eczema Cream Wins Japanese Approval for Children Under 12 | 4 | Tokyo Brief | ||
| 09.09. | StemRIM's Shionogi-Partnered Stroke Drug Misses Its Primary Endpoint While a Rare-Disease Trial Delivers | - | Tokyo Brief | ||
| 05.08. | Shionogi CEO says firm is pursuing acquisitions and mulling expanded U.S. production | 3 | Japan Times | ||
| 03.08. | Shionogi & Co. GAAP EPS of ¥114.78, revenue of ¥163.31B; reaffirms FY 2027 outlook | 6 | Seeking Alpha | ||
| 03.08. | Shionogi & Co., Ltd. Bottom Line Advances In Q1 | 446 | AFX News | TOKYO (dpa-AFX) - Shionogi & Co., Ltd. (SGIOF) announced a profit for its first quarter that Increased, from the same period last yearThe company's bottom line came in at JPY97.696 billion,... ► Artikel lesen | |
| 20.07. | Shionogi & Co., Ltd. Unsponsored ADR (SGIOY) to Report Q1 Results: Wall Street Expects Earnings Growth | 4 | Zacks | ||
| 15.06. | UBS stuft Shionogi-Aktie hoch: Günstige Bewertung und Pipeline als Kaufargumente | 10 | Investing.com Deutsch | ||
| 01.06. | Shionogi's COVID antiviral Xocova passes muster with FDA as post-exposure preventative | 6 | FiercePharma | ||
| 12.05. | Shionogi & Co., Ltd. Profit Climbs In Full Year | 570 | AFX News | TOKYO (dpa-AFX) - Shionogi & Co., Ltd. (SGIOF) revealed earnings for its full year that Increased, from last yearThe company's bottom line totaled JPY205.159 billion, or JPY241.04 per share.... ► Artikel lesen | |
| 07.04. | Shionogi USA: ESCMID Global 2026: Shionogi Presents New Real-World Data Highlighting Clinical Effectiveness of Fetroja/Fetcroja (cefiderocol) in MBL-Producing Enterobacterales Infections | 650 | Business Wire | Real-world evidence study carried out in Spain demonstrates 68% clinical cure rate at day 14, and 83% overall survival at day 28, for patients infected with highly resistant metallo-beta lactamase... ► Artikel lesen | |
| 10.02. | Cumulus Neuroscience Enters Japanese Market to Advance Novel Cognitive Biomarkers with New Customer Shionogi & Co., Ltd. | 697 | PR Newswire | BELFAST, Northern Ireland, Feb. 10, 2026 /PRNewswire/ -- Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on advancing neuroscience clinical trials and... ► Artikel lesen |
1 2 Weiter >>
23 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TRULIEVE CANNABIS | 9,906 | +1,84 % | XFRA NEW INSTRUMENTS AVAILABLE ON 19.08.2026 | The following instruments on XETRA do have their first trading 19.08.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 19.08.2026
Aktien
1 US6420451089 Atlas Energy Solutions... ► Artikel lesen | |
| WEST PHARMACEUTICAL SERVICES | 348,10 | 0,00 % | West Pharmaceutical declares $0.26 dividend | ||
| SHIONOGI | 17,515 | +2,43 % | Dividendenbekanntmachungen (29.09.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) 77 BANK LTD JP3352000008 52 JPY 0,2906 EUR ACADIAN TIMBER CORP CA0042721005 0,29 CAD 0,1799 EUR ACOM CO LTD JP3108600002 11 JPY 0... ► Artikel lesen | |
| KALA BIO | 0,186 | +0,27 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.10.2026 -4- | The following instruments on Boerse Frankfurt do have their last trading day on 02.10.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.10.2026ISIN NameUS1509643029 CENNTRO... ► Artikel lesen | |
| CHARLOTTES WEB | 0,191 | 0,00 % | Charlotte's Web Holdings, Inc.: Charlotte's Web and Edibles.com Team up to Protect Consumer Access and Shape Hemp's Future | Louisville, Colorado--(Newsfile Corp. - August 25, 2026) - Charlotte's Web Holdings, Inc. (TSX: CWEB) (OTCQX: CWBHF), a market leader in hemp wellness, and Edibles.com, a premier retailer and online... ► Artikel lesen | |
| MIRUM PHARMACEUTICALS | 73,28 | 0,00 % | Mirum Pharmaceuticals, Inc.: Mirum Pharmaceuticals gibt bekannt, dass der primäre Endpunkt in der Phase-3-Studie AZURE-1 zu Brelovitug bei chronischer Hepatitis-Delta-Virus-Infektion erreicht wurde | - Der primäre Endpunkt der Phase-3-Studie (virologisches Ansprechen und Normalisierung der ALT-Werte) wurde in beiden Dosierungsgruppen in Woche 24 erreicht - Daten nach 48 Wochen aus dem Phase-2b-Teil... ► Artikel lesen | |
| BEXIMCO PHARMACEUTICALS | 0,620 | 0,00 % | Beximco Pharmaceuticals settles dispute with Bangladesh regulator | ||
| LUYE PHARMA | 0,178 | -1,11 % | LUYE PHARMA (02186): INTERIM REPORT 2026 | ||
| PERCHERON THERAPEUTICS | 0,003 | +25,00 % | PERCHERON THERAPEUTICS LIMITED: Completion of HMBD-002 Drug Product Manufacture | ||
| AVANT BRANDS | 0,306 | +10,87 % | Avant Brands, Inc.: Avant Brands Reports Q3 2026 Results Highlighted by Positive Net Income and 51% Growth in Recreational Revenue | Net income of $0.2 million, compared to a net loss of $1.9 million in Q3 2025Adjusted EBITDA¹ of $1.3 million, compared to $0.2 million in Q3 2025Flowr kilograms harvested increased 57.5%, from 807... ► Artikel lesen | |
| AYURCANN | 0,001 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.07.2026 | The following instruments on Boerse Frankfurt do have their last trading day on 02.07.2026
Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.07.2026
ISIN Name
CA05476A1012... ► Artikel lesen | |
| EVEREST MEDICINES | 3,780 | -2,07 % | Everest Medicines Limited: Two Former Moderna Cancer Vaccine Scientists Join Everest Medicines, Accelerating Global Development of Its mRNA Platform | HONG KONG, Oct 9, 2026 - (ACN Newswire) - Everest Medicines (1952.HK) announced the appointments of Lakshmi Srinivasan, PhD, as Senior Vice President, Head of Translational Medicine, and Brandon Coder... ► Artikel lesen | |
| KALBE FARMA | 0,028 | 0,00 % | Dividendenbekanntmachungen (04.06.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) A-LIVING SMART CITY SERVICES CO LTD CNE100002RY5 0,0688 HKD 0,0075 EUR ADESSO SE DE000A0Z23Q5 - 0,78 EUR AGEAS SA/NV ADR US00844W2089 2... ► Artikel lesen | |
| KOBAYASHI PHARMACEUTICAL | 41,200 | +1,98 % | Dividendenbekanntmachungen (29.06.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AGC INC JP3112000009 105 JPY 0,5701 EUR ALTER EGO MEDIA SA GRS541003000 - 0,03 EUR AOZORA BANK LTD JP3711200000 23 JPY 0,1248... ► Artikel lesen | |
| TEVA PHARMACEUTICAL INDUSTRIES | 40,180 | -0,04 % | Teva/Sanofi: Duvakitug Maintains Meaningful Efficacy Improvements In Long-term Extension Study | PETAH TIKVA (dpa-AFX) - Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries (TEVA), and Sanofi announced new positive data from the RELIEVE UCCD phase 2b long-term extension... ► Artikel lesen |
Das Unternehmen SHIONOGI & CO LTD ADR kann der Branche Pharma zugeordnet werden. Die relative Kursveränderung beträgt aktuell +0,61 % bei einem Aktienkurs von 8,200 Euro. Die Dividendendrendite beträgt aktuell 0,00 % (berechnet anhand der Ausschüttung von 0,00 Euro in den letzten 12 Monaten).
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SHIONOGI & CO LTD ADR finden Sie auf Wallstreet Online.